Evidence-Based Medicine Guidelines
Intravenous immunoglobulin for exacerbations of myasthenia gravis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravenous Immunoglobulin for Exacerbations of Myasthenia Gravis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/453264/all/Intravenous_immunoglobulin_for_exacerbations_of_myasthenia_gravis.
Intravenous immunoglobulin for exacerbations of myasthenia gravis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/453264/all/Intravenous_immunoglobulin_for_exacerbations_of_myasthenia_gravis. Accessed October 6, 2024.
Intravenous immunoglobulin for exacerbations of myasthenia gravis. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/453264/all/Intravenous_immunoglobulin_for_exacerbations_of_myasthenia_gravis
Intravenous Immunoglobulin for Exacerbations of Myasthenia Gravis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/453264/all/Intravenous_immunoglobulin_for_exacerbations_of_myasthenia_gravis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravenous immunoglobulin for exacerbations of myasthenia gravis
ID - 453264
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453264/all/Intravenous_immunoglobulin_for_exacerbations_of_myasthenia_gravis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
